Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with biaryl P4 motifs

Bioorg Med Chem Lett. 2008 Jan 1;18(1):23-7. doi: 10.1016/j.bmcl.2007.11.023. Epub 2007 Nov 17.

Abstract

Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa (fXa) inhibitors, incorporating biaryl P4 groups, producing highly potent inhibitors with encouraging oral pharmacokinetic profiles and significant but sub-optimal anticoagulant activities.

MeSH terms

  • Animals
  • Anticoagulants / chemistry
  • Anticoagulants / pharmacokinetics
  • Anticoagulants / pharmacology
  • Drug Design
  • Factor Xa Inhibitors*
  • Male
  • Models, Molecular
  • Pyrrolidinones / chemistry*
  • Pyrrolidinones / pharmacokinetics
  • Pyrrolidinones / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Serine Proteinase Inhibitors / chemistry*
  • Serine Proteinase Inhibitors / pharmacokinetics
  • Serine Proteinase Inhibitors / pharmacology*
  • Structure-Activity Relationship
  • Sulfonamides / chemistry
  • Sulfonamides / pharmacokinetics
  • Sulfonamides / pharmacology

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Pyrrolidinones
  • Serine Proteinase Inhibitors
  • Sulfonamides

Associated data

  • PDB/2VH6